Item 389 | First Year - FY2019 | Second Year - FY2020 |
|---|---|---|
| Operation of State Residential Community Correctional Facilities (36100) | $17,503,006 | $18,663,154 |
| Community Facility Management (36101) | FY2019 $1,406,592 | FY2020 $1,406,592 |
| Supervision and Management of Probates (36102) | FY2019 $11,240,304 | FY2020 $11,240,304 |
| Rehabilitation and Treatment Services - Community Residential Facilities (36103) | FY2019 $1,838,499 | FY2020 $2,998,647 |
| Medical and Clinical Services - Community Residential Facilities (36104) | FY2019 $799,261 | FY2020 $799,261 |
| Food Services - Community Residential Facilities (36105) | FY2019 $1,182,525 | FY2020 $1,182,525 |
| Physical Plant Services - Community Residential Facilities (36106) | FY2019 $1,035,825 | FY2020 $1,035,825 |
| Fund Sources: | ||
| General | FY2019 $16,603,006 | FY2020 $17,763,154 |
| Special | FY2019 $900,000 | FY2020 $900,000 |
Authority: §§ 53.1-67.2 through 53.1-67.8, Code of Virginia.
A. Included within this appropriation is $700,00 the first year and $700,000 the second year from nongeneral funds to be used for operating expenses of diversion centers operated by the Department of Corrections. The nongeneral funds are to come from the fees collected from probationers, assigned to the diversion centers, to cover a portion of the cost of housing them, pursuant to § 19.2-316.3 C, Code of Virginia.
B. Notwithstanding the provisions of § 53.1-67.1, Code of Virginia, the Department of Corrections shall not be required to operate a boot camp program for offenders placed on probation.
C. Included in the appropriation for this Item is $438,936 the first year and $438,936 $1,599,084 the second year from the general fund for the establishment of opioid treatment programs in the detention and diversion centers. The department shall report annually to the Governor, the Chairmen of the House Appropriations and the Senate Finance Committees, and the Department of Planning and Budget on the status of the program, including recidivism and illegal drug relapse of participants in the program.